International Journal of Drug Policy
Volume 13, Issue 3 , Pages 225-235, September 2002

A critical reading of the World Drug Report 2000

  • Carla Rossi

      Affiliations

    • Corresponding Author InformationTel.: +39-06-725-94676; fax: +39-06-725-94699

Department of Mathematics, University of Rome ‘Tor Vergata’, Via Ricerca scientifica 1, 00133 Rome, Italy

Accepted 15 April 2002.

Abstract 

This essay provides a critical analysis of the United Nations Drug Control Programme's (UNDCP) World Drug Report (WDR, 2000), released on January 22nd 2001. Besides the content of WDR 2000 being far less rich than the content of the previous UNDCP World Drug Report in 1997, a critical analysis suggests that data taken from publications of the European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) and other international agencies has been misrepresented. Such distortions are considered from a methodological point of view, with the original data compared against those reported in WDR (2000). The implications of the biased interpretations for policy making are discussed.

Keywords:  UNDCP, EMCDDA, Drugs, World drug problem, Pino Arlacchi

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This essay was written before Pino Arlacchi relinquished his duties as Executive Director of the UN Office for Drug Control and Crime Prevention (which includes UNDCP) on 31 December 2001. Antonio Costa took up the duties of Executive Director on 7 May 2002.

PII: S0955-3959(02)00074-9

doi:10.1016/S0955-3959(02)00074-9

International Journal of Drug Policy
Volume 13, Issue 3 , Pages 225-235, September 2002